The honest answer — it varies enormously
Most patient information about antidepressant withdrawal says symptoms last "a few days to a few weeks." For a significant proportion of people, this is simply not accurate.
Clinical research, updated NICE guidelines, and the accumulated experience of patients have established that withdrawal can last:
- A few days to two weeks — for short-term users reducing slowly from a lower dose
- Several weeks to three months — for many people on standard doses for one to three years
- Several months to a year — for long-term users, those on higher doses, or those who stopped abruptly
- Over a year — in a minority of cases, particularly with prolonged high-dose use of drugs with short half-lives such as venlafaxine or paroxetine
The NICE guideline on depression (NG222) now explicitly acknowledges that withdrawal symptoms can last "several months" — a significant departure from the "few weeks" framing that dominated clinical guidance for decades.
Factors that affect how long withdrawal lasts
Duration of use
The longer someone has been on an antidepressant, the more comprehensively the brain has adapted to its presence — and the longer it may take to readjust. Someone who took sertraline for three months will typically have a very different experience from someone who has been on it for eight years.
Dose
Higher doses generally mean more extensive neurological adaptation and a longer readjustment period. The final stages of tapering from a high dose can be as challenging as the entire taper from a lower dose.
The medication itself
Half-life is the single most important pharmacological factor. Drugs that leave the body quickly (short half-life) produce more rapid and intense withdrawal. Fluoxetine has a very long half-life and effectively self-tapers — withdrawal is usually mild and brief. Venlafaxine and paroxetine have very short half-lives and are associated with the most prolonged and difficult withdrawal syndromes.
How it was stopped
Abrupt cessation or rapid tapering dramatically increases both the severity and duration of withdrawal. The nervous system is asked to adapt far faster than it can manage. In contrast, a carefully managed hyperbolic taper — reducing slowly and proportionally — typically produces much shorter, milder withdrawal at each step, and a shorter overall recovery period even though the total taper takes longer.
Individual variation
Some people have nervous systems that are more sensitive to pharmacological change than others. This is not a weakness — it reflects genuine biological variation in how quickly the brain adapts and readjusts. People who are highly sensitive to caffeine or alcohol, or who notice drug effects quickly, may also experience more pronounced withdrawal.
What "protracted withdrawal" means
Protracted withdrawal — also called post-acute withdrawal syndrome (PAWS) — refers to withdrawal symptoms that persist for months or longer after stopping a medication. It is recognised in clinical literature and by the Royal College of Psychiatrists, though it remains under-discussed in routine clinical practice.
Characteristic features of protracted withdrawal include:
- Symptoms that fluctuate in waves rather than steadily improving
- Good periods that then worsen unexpectedly, sometimes triggered by stress or illness
- A gradual overall trajectory of improvement even when individual days or weeks are difficult
- Sensory symptoms — brain zaps, tingling, hypersensitivity — persisting beyond the acute phase
Protracted withdrawal does not mean permanent damage. The vast majority of people recover fully. Understanding that fluctuations are part of the recovery pattern — rather than signs of relapse — is clinically important.
| Medication | Half-life | Typical withdrawal duration (with careful taper) |
|---|---|---|
| Fluoxetine (Prozac) | 4–6 days | Minimal — often days to a few weeks |
| Sertraline (Lustral) | 26 hours | Weeks to 2–3 months for long-term users |
| Citalopram / Escitalopram | 35 / 27 hours | Weeks to 2–3 months |
| Mirtazapine | 20–40 hours | Weeks to months — sleep often most persistent |
| Duloxetine (Cymbalta) | 12 hours | Weeks to several months |
| Paroxetine (Seroxat) | 21 hours (but complex) | Months — one of the most prolonged |
| Venlafaxine (Efexor) | 5 hours | Months to over a year in some cases |
What helps withdrawal resolve more quickly
- Slowing the taper — counterintuitively, a slower taper usually means a shorter and milder withdrawal at each step
- Holding the dose — when withdrawal symptoms are significant, holding the current dose until they settle is more effective than pushing through
- Sleep support — sleep disruption is one of the most persistent withdrawal symptoms and one that, when poorly managed, prolongs recovery. Addressing sleep hygiene and reducing stimulants helps significantly
- Reducing other stressors — the nervous system cannot simultaneously manage medication withdrawal and significant life stress. Where possible, timing the taper to a period of relative stability helps
- Clinical support — having a framework for interpreting symptoms reduces fear-driven decisions, which are themselves a major cause of prolonged difficulty
Our approach
How we manage withdrawal duration
Our deprescribing plans are paced to minimise withdrawal at each step — not to reach zero as quickly as possible. We monitor closely, adjust when needed, and provide a clear clinical framework for interpreting what is happening throughout the process. Most people find that a well-managed taper feels very different from previous attempts.
Book an Initial ConsultationReferences
- Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects. Addictive Behaviors. 2019;97:111–121. DOI: 10.1016/j.addbeh.2018.08.027
- Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychotherapy and Psychosomatics. 2015;84(2):72–81. DOI: 10.1159/000370338
- National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. London: NICE; 2022.
- Horowitz MA, Taylor D. The Maudsley Deprescribing Guidelines. Wiley-Blackwell; 2024. ISBN: 978-1119822981
- Royal College of Psychiatrists. Stopping antidepressants. 2020. Available at: rcpsych.ac.uk
Related reading
Withdrawal does not last forever — even when it feels that way.
The nervous system has a remarkable capacity to recover. What it needs is time, a sensible pace, and support from someone who understands what is happening.